Gene engineered exosome reverses T cell exhaustion in cancer immunotherapy
Cancer patients by immune checkpoint therapy have achieved long-term remission, with no recurrence of clinical symptoms of cancer for many years. Nevertheless, more than half of cancer patients are not responsive to this therapy due to immune exhaustion. Here, we report a novel gene engineered exoso...
Main Authors: | Peishan Li, Ying Xie, Jinling Wang, Chunjie Bao, Jialun Duan, Yixuan Liu, Qian Luo, Jiarui Xu, Yuxin Ren, Min Jiang, Jianwei Li, Haitao Guo, Huihui Zhao, Guiling Wang, Yanqin Liang, Wanliang Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2024-04-01
|
Series: | Bioactive Materials |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X24000082 |
Similar Items
-
Multipl miyelom’da CD4+ regülatör T hücrelerin rolü
by: Deniz EKİNCİ, et al.
Published: (2017-09-01) -
Mechanisms of Resistance and Strategies to Combat Resistance in PD-(L)1 Blockade
by: John Moise, et al.
Published: (2022-11-01) -
Investigation of the PD-1/PD-L1 Expression in the Lesional Skins of Patients with Psoriasis
by: Selma Emre, et al.
Published: (2023-04-01) -
Association between <i>AHR</i> Expression and Immune Dysregulation in Pancreatic Ductal Adenocarcinoma: Insights from Comprehensive Immune Profiling of Peripheral Blood Mononuclear Cells
by: Arenida Bartkeviciene, et al.
Published: (2023-09-01) -
Effect of Rapamycin on Exosomes and PD-1/PD-L1 in Human Erythroleukemia HEL Cells
by: QI Lin, et al.
Published: (2022-10-01)